| English Alias: |
Bosutinib;4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile;Bosutinib (SKI-606);Bosutinib (SKI-606,WAY-173606, Bosulif®);Bosutinib(SKI 606);Pneumocandin B1; Bosutinib for research;SKI-606;WAY-173606;SKI 606;SKI606;BOSULIF;4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile;5018V4AEZ0;4-(2,4-dichloro-5-methoxya;4-((2,4-dichloro-5-;4-Anilinobenzo(g)quinoline-3-carbonitrile;BOSUTINIB [WHO-DD];MFCD07367846;HY-10158;EC 700-455-1;BDBM4552;NSC799367;DB06616;BOSUTINIB [MI];Q894611;2-PYRIDIN-2-YLETHYLACETATE;NSC765694;SCHEMBL158390;S1014;A25014;HMS3672K11;PF-5208763;FT-0656231;MLS006011212;BCP01782;SMR002530350;C26H29Cl2N5O3;UNII-5018V4AEZ0;BOSUTINIB [INN];SKI606; SKI 606; SK-I606;3-QUINOLINECARBONITRILE, 4-((2,4-DICHLORO-5-METHOXYPHENYL)AMINO)-6-METHYL-1-PIPERAZINYL)PROPOXY)-;SR-01000941572;SK-606;SKI-606;4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile;380843-75-4;SW220197-1;L01XE14;Z2216885221;AB01565836_03;bosutinibum;BOSUTINIB (MART.);HMS3743E09;AKOS015902521;Bosutinib [USAN:INN];HB1323;BRD-K99964838-001-01-0;NS00002757;CHEMBL288441;BRD-K99964838-001-06-9;UBPYILGKFZZVDX-UHFFFAOYSA-N;AC-2413;PB30881;CCG-208129;Bosutinib, >=98% (HPLC);BCPP000318;Bosutinib (USAN);4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile;NCGC00241107-01;Bosutinib (SKI606);SR-01000941572-1;J-519931;SK 606;NSC-765694;DTXSID10861568;NCGC00241107-05;Q-200745;EN300-7565041;GTPL5710;HMS2043A22;HMS3651C03;D03252;SKI-606);NCGC00241107-03;BOSUTINIB [MART.];4-(2,4-Dichloro-5-methoxy-phenylamino)-6-methoxy-7-[3-(4-methyl-piperazin-1-yl)propoxy]quinoline-3-carbonitrile;CS-0118;3-Quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-;Bosutinib [USAN];HMS3244B03;4-(2,4-dichloro-5-methoxyphenylamino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile;HMS3244A03;NSC-799367;BCP9000446;K00615a;4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;HMS3244A04;Bosutinib,SKI-606;BOSUTINIB [VANDF];AMY266;CHEBI:39112;BOSUTINIB ISOMER 1;4-(2,4-dichloro-5-methoxy-anilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;AS-11064;EX-A391;SDCCGSBI-0646926.P001;BRD-K99964838-001-11-9;BRD-K99964838-001-12-7;Bosutinib (SKI-606)? |
3-Thiophenecarboxylic acid, 5-(4-aminophenyl)-2-[[(2,6-difluorophenyl)methyl](ethoxycarbonyl)amino]-4-[(dimethylamino)methyl]-, ethyl ester, hydrochloride
Cas No: 2768834-98-4
1-ETHYL-7-CHLORO-6-FLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID
Cas No: 68077-26-9
2-Methyl-3-tritylamino-4-(2-N-bocamino)ethylaminoacarbonylamino-2H-pyrazole
Cas No: 689293-69-4
